Anúncio
Anúncio

HCA

HCA logo

HCA Healthcare, Inc.

466.69
USD
Patrocinado
-6.57
-1.39%
31 de dez., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

466.60

-0.10
-0.02%

Relatórios de Lucros HCA

Rácio de surpresa positiva

HCA separação 26 de 39 últimas estimativas.

67%

Próximo Relatório

Data do Próximo Relatório
22 de jan. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$19.86B
/
$7.50
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+3.66%
/
+7.76%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+8.63%
/
+33.21%

HCA Healthcare, Inc. earnings per share and revenue

On 24 de out. de 2025, HCA reported earnings of 6.96 USD per share (EPS) for Q3 25, beating the estimate of 5.77 USD, resulting in a 20.55% surprise. Revenue reached 19.16 bilhão, compared to an expected 18.75 bilhão, with a 2.21% difference. The market reacted with a +1.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 23 analistas forecast an EPS of 7.50 USD, with revenue projected to reach 19.86 bilhão USD, implying an aumentar of 7.76% EPS, and aumentar of 3.66% in Revenue from the last quarter.
FAQ
For Q3 2025, HCA Healthcare, Inc. reported EPS of $6.96, beating estimates by 20.55%, and revenue of $19.16B, 2.21% above expectations.
The stock price moved up 1.56%, changed from $440.16 before the earnings release to $447.04 the day after.
The next earning report is scheduled for 22 de jan. de 2026.
Based on 23 analistas, HCA Healthcare, Inc. is expected to report EPS of $7.50 and revenue of $19.86B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio